WuXi AppTec wuxiapptec.com


Public list: BIO 2016 (619) Medical Devices (6123)

WuXi AppTec (药明康德) (SH: 603259), founded in 2010, is a global pharmaceutical, biopharmaceutical, and medical device open-access capability and technology platform with operations in China and the United States. The company provides a broad and integrated portfolio of services throughout the drug R&D process. WuXi AppTecs's services are designed to help their worldwide customers shorten the discovery and development time and lower the cost of drug and medical device R&D through cost-effec...Show all

WuXi AppTec (药明康德) (SH: 603259), founded in 2010, is a global pharmaceutical, biopharmaceutical, and medical device open-access capability and technology platform with operations in China and the United States. The company provides a broad an...Show all

Company (IPO / Went public)

Phone: +86 (21) 5046-1111

Fax: +86 (21) 5046-1000

288 Fute Zhong Road
Waigaoqiao Free Trade Zone
Shanghai, 200131
Shanghai, China

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
WuXi AppTec $1855.3M Apr 25, 2018
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related WuXi AppTec Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
General AtlanticGrowth EquityGreenwich, Connecticut, United StatesOther Investors
Thomas McNerney & PartnersVenture CapitalStamford, Connecticut, United StatesOther Investors
Ping An InsuranceCorporationShenzhen, Guangdong, ChinaLine of Credit
See all 3 investors

Competitors

Company Status Description Investors
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Use of tumor dissociation reagent in flow cytometry Apr 13, 2017 Application